Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Exchange Rate Effect (2016 - 2025)

IGC Pharma (IGC) has disclosed Exchange Rate Effect for 16 consecutive years, with $5000.0 as the latest value for Q3 2025.

  • Quarterly Exchange Rate Effect rose 145.45% to $5000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $32000.0 through Sep 2025, up 633.33% year-over-year, with the annual reading at -$7000.0 for FY2025, 16.67% down from the prior year.
  • Exchange Rate Effect for Q3 2025 was $5000.0 at IGC Pharma, down from $25000.0 in the prior quarter.
  • The five-year high for Exchange Rate Effect was $25000.0 in Q2 2025, with the low at -$52000.0 in Q2 2022.
  • Average Exchange Rate Effect over 5 years is -$5111.1, with a median of $1000.0 recorded in 2023.
  • The sharpest move saw Exchange Rate Effect plummeted 3900.0% in 2022, then soared 1150.0% in 2025.
  • Over 5 years, Exchange Rate Effect stood at $14000.0 in 2021, then tumbled by 192.86% to -$13000.0 in 2022, then surged by 107.69% to $1000.0 in 2023, then tumbled by 1200.0% to -$11000.0 in 2024, then skyrocketed by 145.45% to $5000.0 in 2025.
  • According to Business Quant data, Exchange Rate Effect over the past three periods came in at $5000.0, $25000.0, and $2000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.